Pfizer funds "new model" of unbiased CME in US with $3 million to Stanford
This article was originally published in Scrip
Executive Summary
Stanford University School of Medicine is developing new continuing medical education (CME) courses for physicians which are free from influence from the pharmaceutical industry, despite being funded by a three-year, $3 million grant from Pfizer. But the move has not put to rest the ongoing controversy over how to fund US CME, in which doctors are required to participate on a regular basis.